Abstract
Introduction: Eculizumab, which is indicated to treat patients with paroxysmal nocturnal hemoglobinuria (PNH), is a life-changing, life-saving therapy......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
